Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration
Journal of Neurochemistry · 2026
DOI: 10.1111/jnc.70547 ↗At a glance
Journal article in Journal of Neurochemistry, 2026. Written by Roberto García-Swinburn and 8 co-authors. Institution: Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain. Major MEDLINE topics: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Aging, Neuroinflammatory Diseases, Substantia Nigra. 76 references. The full text is freely available (open access, CC BY 4.0). Funded by: Agencia Estatal de Investigación, Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía, Consejería de Salud y Familias, Junta de Andalucía.
Abstract (original language)
LRRK2 G2019S mutation is the most common genetic cause of Parkinson's disease (PD) producing clinical manifestations similar to sporadic PD patients, hinting at the relevance of this mutation in the pathophysiological mechanisms of the disease. However, its role potentiating nigrostriatal neurodegeneration, particularly in response to mitochondrial dysfunction, remains unclear. Here, using histological, neurochemical and behavioral analyzes, we provide a complete characterization of a mouse model expressing the human LRRK2 G2019S mutation (hLRRK2*G2019S mice), in the context of aging and toxin‐induced parkinsonism. hLRRK2*G2019S young adult mice showed significant microglial activation and deficits in motor coordination, whereas aged transgenic displayed a hyperactive phenotype, despite the absence of evidence for nigrostriatal neurodegeneration in either young adult or aged animals. Furthermore, we assessed the vulnerability of LRRK2*G2019S transgenic mice to the chronic exposure to the mitochondrial complex I inhibitor 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). Notably, no exacerbation of nigrostriatal neurodegeneration was observed in hLRRK2*G2019S mice, suggesting that this mutation does not increase sensitivity to mitochondrial stress. However, hLRRK2*G2019S MPTP‐treated mice present alterations, relative to WT counterparts, in the glial response induced by the neurotoxic treatment. These findings suggest that the G2019S mutation modulates the neuroimmune response but does not exacerbate nigrostriatal neurodegeneration in response to mitochondrial dysfunction. This highlights the mutation's complex role in PD pathophysiology. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
- Departamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain.
- Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
ORCID profiles: Roberto García-Swinburn, Laura Morón-Márquez, Carmen Conde-Naranjo, Ernesto García-Roldán, Isabel Espadas, Alfonso Rodríguez-Gil, Reposo Ramírez-Lorca, Javier Villadiego, Juan José Toledo-Aral
Funding
- Agencia Estatal de Investigación
- Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía
- Consejería de Salud y Familias, Junta de Andalucía
Cite
APA
García-Swinburn, R., Morón-Márquez, L., Conde-Naranjo, C., García-Roldán, E., Espadas, I., Rodríguez-Gil, A., Ramírez-Lorca, R., Villadiego, J., & Toledo-Aral, J. J. (2026). Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70547
Vancouver
García-Swinburn R, Morón-Márquez L, Conde-Naranjo C, García-Roldán E, Espadas I, Rodríguez-Gil A, et al. Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration. Journal of Neurochemistry. 2026. doi:10.1111/jnc.70547
BibTeX
@article{GarcaSwinburn2026,
author = {García-Swinburn, Roberto and Morón-Márquez, Laura and Conde-Naranjo, Carmen and García-Roldán, Ernesto and Espadas, Isabel and Rodríguez-Gil, Alfonso and Ramírez-Lorca, Reposo and Villadiego, Javier and Toledo-Aral, Juan José},
title = {Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration},
journal = {Journal of Neurochemistry},
year = {2026},
doi = {10.1111/jnc.70547}
}
EUVIMED